Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Adamant Biotech

+ Add to Watchlist

BBBIOGI:LX

397.99 GBP 1.04 0.26%

As of 08:26:00 ET on 05/28/2015.

Snapshot for Bellevue Funds Lux - BB Adamant Biotech (BBBIOGI)

Year To Date: +23.52% 3-Month: +7.21% 3-Year: +45.07% 52-Week Range: 225.39 - 422.96
1-Month: +5.87% 1-Year: +76.34% 5-Year: - Beta vs LUXXX: 0.72

Mutual Fund Chart for BBBIOGI

No chart data available.
  • BBBIOGI:LX 397.99
  • 1M
  • 1Y
Interactive BBBIOGI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBBIOGI

Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.

Inception Date: 03-30-2012 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER
Web Site: www.bellevuegroup.com

Fundamentals for BBBIOGI

NAV (on 2015-05-28) 397.99
Assets (M) (on 2015-05-28) 98.33
Fund Leveraged N
Minimum Investment 500,000.00
Minimum Subsequent Investment -

Dividends for BBBIOGI

No dividends reported

Fees & Expenses for BBBIOGI

Front Load -
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BBBIOGI

Filing Date: 04/30/2015
Name Position Value % of Total
Biogen Inc 20,000 7,478,600 7.731%
Gilead Sciences Inc 72,000 7,236,720 7.481%
Celgene Corp 63,000 6,807,780 7.038%
Amgen Inc 30,866 4,874,050 5.039%
Mylan NV 55,000 3,974,300 4.109%
Vertex Pharmaceuticals Inc 28,500 3,513,480 3.632%
Alexion Pharmaceuticals Inc 20,746 3,510,846 3.629%
Regeneron Pharmaceuticals Inc 7,595 3,474,409 3.592%
Incyte Corp 33,352 3,240,480 3.350%
Medivation Inc 24,300 2,933,982 3.033%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil